A novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway disease.

Sci Rep · 2016 · PMC5062168 · PMID 27734946

Europe PMC DOI

hedged sentence

0.1300

closest p · 2.6× alpha

0.1300

boldest claim

The sentences

showed a trendp = 0.13not close (p > 0.1)

Similarly, KB showed a trend for attenuation of HDM exposure induced IL-13 levels (p = 0.13).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.